Seeking Alpha

FDA staff are skeptical that Abbott's (ABT) Humira drug, which is already cleared for rheumatoid...

FDA staff are skeptical that Abbott's (ABT) Humira drug, which is already cleared for rheumatoid arthritis, is effective in treating ulcerative colitis in patients who don't respond to conventional medicines. Although two trials of Humira met the studies' goals, on Friday the FDA questioned the "clinical meaningfulness" of the results. An advisory panel is due to meet on Tuesday.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs